Cardlytics (CDLX) Receives a Buy from Craig-Hallum

In a report released today, Jason Kreyer from Craig-Hallum maintained a Buy rating on Cardlytics (CDLX – Research Report). The company’s shares opened today at $12.35.

Kreyer covers the Communication Services sector, focusing on stocks such as Cardlytics, Magnite, and Integral Ad Science. According to TipRanks, Kreyer has an average return of 8.7% and a 46.69% success rate on recommended stocks.

Currently, the analyst consensus on Cardlytics is a Strong Buy with an average price target of $17.67.

The company has a one-year high of $20.52 and a one-year low of $4.94. Currently, Cardlytics has an average volume of 1.69M.

Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CDLX in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cardlytics (CDLX) Company Description:

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.